GGrantIndex
Sort

23,748 grants matching melanoma

(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity

$502,619
Nir Hacohen · Broad Institute, Inc. · R01 · FY2019 · CA

Sensitivity and specificity of line-scanning versus point-scanning reflectance confocal microscopy for detecting melanocytic skin lesions in vivo

$502,382
Milind Rajadhyaksha · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA

DISPLAY METHODS FOR SURVEYING MUTATIONS

$502,338
Yale University · R33 · FY2001 · CA

Targeting Hypoxia-Induced Cancer-Cell Adaptation by Direct Inhibition of Akt and

$502,289
Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2010 · CA

IND-Enabling Toxicology for a Novel Ca2+ Channel Therapeutic to Improve Outcomes Associated with Checkpoint Inhibitor Immunotherapy

$502,010
Milton L Greenberg · Vivreon Biosciences, Llc · R44 · FY2024 · CA

An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk

$501,986
Joel J Hillhouse · East Tennessee State University · R01 · FY2014 · CA

SOUTHWEST ONCOLOGY GROUP

$501,965
University Of Rochester · U10 · FY2003 · CA

Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells

$501,962
Eric T Ahrens · University Of California, San Diego · R01 · FY2019 · CA

Primary Project

$501,828
Eva M Sevick-Muraca · University Of Texas Hlth Sci Ctr Houston · U54 · FY2009 · CA

Functional analysis of a novelintegrin-dependent metastasis pathway in melanoma

$501,583
Tobias Schatton · Brigham And Women'S Hospital · R01 · FY2023 · CA

Immunomodulatory Therapy for Neuropathic Pain

$501,320
Ridong Chen · Apt Therapeutics, Inc. · R44 · FY2023 · NS

A comparison of interventions to teach melanoma patients' skin self-examination

$501,257
June K Robinson · Northwestern University At Chicago · R01 · FY2013 · CA

CDKN2A couples lipid metabolism to ferroptosis in glioblastoma

$501,221
David A. Nathanson · University Of California Los Angeles · R01 · FY2024 · NS

Tumor Organoid-Mediated Drug Testing and Clonality Analysis in Peritoneal Surface Disease of Intestinal Origin

$501,170
Konstantinos Votanopoulos · Wake Forest University Health Sciences · R01 · FY2021 · CA

MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER

$501,149
Marco Ruella · University Of Pennsylvania · R37 · FY2024 · CA

Renally Excreted Multimodal Core-Shell Silica Nanoparticles as Tumor-Selective Ra

$501,146
Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA

Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells

$501,116
Eric T Ahrens · University Of California, San Diego · R01 · FY2020 · CA

IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems

$501,022
Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL

Role of MFG-E8 in Tumor Biology and Immunophysiology

$500,788
Mark Udey · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

CANCER AND LEUKEMIA GROUP B

$500,685
Dana-Farber Cancer Institute · U10 · FY2002 · CA

Transduction of T cells to improve migration to tumor

$500,533
Patrick Hwu · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA

HIGH-RESOLUTION IMAGING OF OCULAR MELANOMA AND RETINA

$500,435
University Of California San Diego · R01 · FY2001 · EY

Enhanced Viro-Immunotherapy for Breast Cancer Brain Metastasis

$500,175
Ji Young Yoo · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · CA

Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound

$500,099
Richard J Price · University Of Virginia · R01 · FY2019 · CA

Abramson Cancer Center Support Grant

$500,018
Robert H Vonderheide · University Of Pennsylvania · P30 · FY2020 · CA